BM
Disease and Mutation LabMechanism before phenotype

Genotype → biophysics → phenotype

Change the lesion. Follow what breaks.

Compare a curated cardiac variant with the reference state, add a mechanism-based intervention overlay, and trace the consequences from calcium handling to ventricular output.

thin-filament calcium sensitization

TNNT2 p.Arg92Gln · R92Q

autosomal dominantHypertrophic cardiomyopathy
02Calcium and force through one cycle
referenceselected state
CYTOSOLIC Ca²⁺ACTIVE FORCE00.5 cycle1.0
Peak active force2.50×relative to the reference beatfitted
Thin-filament activation44%+23 points of maximumsimulated
Relaxation t½158 ms+37 ms vs referencesimulated
End-diastolic pressure7.9 mmHg+2.5 mmHg vs referencefitted
LV ejection fraction73%+13 points vs referencefitted
End-diastolic volume111 mL-4 mL vs referencefitted
01 · Molecular lesion

The thin filament activates at lower cytosolic Ca²⁺, represented by a left-shifted force–calcium relation.

02 · Cellular physiology

More force persists while calcium falls, increasing residual diastolic tension and energetic demand.

03 · Organ phenotype

A smaller, stiffer chamber can remain hyperdynamic while filling pressure rises.

The molecule itself

Look at what the lesion actually changes.

Every trace above is driven by a parameter. This is the protein those parameters stand for, traced from the mmCIF this deployment has cached — the same bytes the download gives you.

6KN7Cardiac thin filament · calcium-free, Arg92 resolved
troponin Trest of the complex
The same filament in the calcium-free state, troponin T lit and Arg92 pinned. Cryo-EM at 6.6 Å. RCSB 6KN7

Intervention reasoning

See the tradeoff, not just the endpoint.

The untreated selected state remains visible while the overlay changes only its encoded target mechanisms. Reference physiology is retained as a separate anchor.

Ventricular consequencePressure-volume comparison
referenceuntreated variantoverlay
050100150050100150mmHgLV volume (mL)
Overlay EF73%fittedStroke volume80 mLfittedCardiac output6.46 L/minfitted

Evidence map

Separate observation from translation.

The direction of each primary molecular effect is literature-grounded. Numeric parameter sizes and organ-scale consequences are teaching assumptions.

TNNT2p.Arg92Gln · R92QHypertrophic cardiomyopathy
Supported direction

The thin filament activates at lower cytosolic Ca²⁺, represented by a left-shifted force–calcium relation.

Model translation

A smaller, stiffer chamber can remain hyperdynamic while filling pressure rises.

Open evidence source ↗
MYBPC3loss-of-function classHypertrophic cardiomyopathy
Supported direction

Less cardiac myosin-binding protein C shifts myosin heads out of the energy-sparing super-relaxed state.

Model translation

Hypercontractility and impaired relaxation in a relatively small, stiff chamber.

Open evidence source ↗
TNNT2p.Lys210del · ΔK210Dilated cardiomyopathy
Supported direction

The thin filament needs more Ca²⁺ for the same activation, represented by a right-shifted force–calcium relation.

Model translation

Lower elastance with compensatory dilation gives a wider chamber and reduced ejection fraction.

Open evidence source ↗
RYR2p.Arg4496Cys · R4496CCatecholaminergic polymorphic VT
Supported direction

Destabilized RyR2 gating permits spontaneous sarcoplasmic-reticulum Ca²⁺ release during diastole.

Model translation

Pump output stays near normal while electrical instability rises sharply with adrenergic drive.

Open evidence source ↗
Directly sourcedVariant and mechanism direction

For example, calcium sensitization, desensitization, or stress-dependent RyR2 leak.

Phenotype-inspiredParameter magnitudes

Compliance, chamber filling, reserve, and energetic multipliers are selected for interpretable teaching behavior.

CalculatedTraces and hemodynamics

Calcium occupancy, force, pressure-volume loops, EF, and output emerge from the reduced model.

Not calculatedClinical risk and prognosis

Penetrance, fibrosis, LVOT anatomy, ECG behavior, sudden-death risk, and treatment response remain outside scope.

Interpretation boundary

The simulator isolates selected mechanisms and then propagates them through a reduced cardiac model. It does not estimate penetrance, clinical severity, sudden-death risk, treatment response, or prognosis for a person carrying a variant.